Unique case of caecum plasmablastic lymphoma CD138+ in patient with late diagnosed colon neuroendocrine carcinoma;Rzadki przypadek wystȩpowania chłoniaka plazmoblastycznego ka̧tnicy (plasmablastic lymphoma CD138+) u chorego z późno rozpoznanym rakiem neuroendokrynnym jelita grubego

Endokrynologia Polska

Volumn 57, Issue 2, 2006, Pages 160-165

  Foltyn, Wanda ^a   Kos Kudła, Beata ^a   Siemiñska, Lucyna ^a   Zemczak, Anna ^a   Strzelczyk, Janusz ^a   Marek, Bogdan ^a   Kajdaniuk, Dariusz ^a   Nowak, Mariusz ^a   Borowska, Małgorzata ^a   Jurecka Lubienicka, Beata ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Neuroendocrine tumors; Plasmablastic lymphoma CD138+

Indexed keywords

SYNDECAN 1; TUMOR MARKER;

ARTICLE; B CELL LYMPHOMA; CARCINOMA; CASE REPORT; CECUM TUMOR; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PLASMA CELL; SECOND CANCER; TREATMENT OUTCOME;

CARCINOMA, NEUROENDOCRINE; CECAL NEOPLASMS; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PLASMA CELLS; SYNDECAN-1; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 39049194989     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Calender A. Molecular genetics of neuroendocrine tumors. Digestion 2000; 62 (supl 1): 3-18. (Pubitemid 30665934)
2. Prommegger R, Ensinger C, Steiner P i wsp. Neuroendocrine tumors and second primary malignancy-a relationship with clinical impact? Anticancer Res 2004; 24 (2C): 1049-1051. (Pubitemid 38624936)
3. Delecluse HJ, Anagnostopoulos I, Dallenbach F i wsp. Plasma-blastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 15; 89 (4): 1413-1420. (Pubitemid 27080006)
4. Teruya-Feldstein J, Chiao E, Filippa DA i wsp. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and-negative patients. Ann Oncol 2004; 15 (11): 1673-1679. (Pubitemid 39562609)
5. Lin O, Gerhard R, Zerbini MC i wsp. Cytologic features of pla-smablastic lymphoma. Cancer 2005; 105 (3): 139-144.
6. Vega F, Chang CC, Medeiros LJ i wsp. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005; 18 (6): 806-815. (Pubitemid 40780514)
7. Scheper MA, Nikitakis NG, Fernandes R i wsp. Oral plasma-blastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100 (2): 198-206.
8. Pruneri G, Graziadei G, Ermellino L i wsp. Plasmablastic lym-phoma of the stomach. A case report. Haematologica 1998; 83 (1): 87-89. (Pubitemid 28096505)
9. Lin Y, Rodrigues GD, Turner JF i wsp. Plasmablastic lympho-ma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med 2001; 125 (2): 282-285. (Pubitemid 32167487)
10. Chetty R, Hlatswayo N, Muc R i wsp. Plasmablastic lympho-ma in HIV+ patients: an expanding spectrum. Histopatholo-gy 2003; 42 (6): 605-609. (Pubitemid 36688156)
11. Cwikła J. Diagnostyka obrazowa guzów neuroendokrynnych. Onkologia po Dyplomie (wydanie specjalne) 2005; 31-41.
12. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. En-docr Rev 2004; 25 (3): 458-511. (Pubitemid 38780668)
13. Kos-Kudła B. Guzy neuroendokrynne. Endokrynol Pol 2004; 55: 492-499.
14. Kos-Kudła B. Diagnostyka biochemiczna-markery guzów neuroendokrynnych przewodu pokarmowego. Onkologia po Dyplomie (wydanie specjalne) 2005; 19-24.